| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Jul 07, 2020 |
|||||||||
| Q4 FY20 | $0.61 | $0.61 | $915.10M | $900.10M |
NASDAQ |
||||
|
Levi Strauss
LEVI
|
- | -$0.48 | -$0.50 | $497.54M | $507.91M |
NYSE |
|||
|
Accolade
ACCD
|
- | -$0.05 | - | $44.44M | - |
NASDAQ |
|||
|
Pure Cycle
PCYO
|
Q3 FY20 | - | - | $1.85M | - |
NASDAQ |
|||
|
Oramed Pharmaceuticals
ORMP
|
- | -$0.10 | -$0.15 | $681K | $1.16M |
NASDAQ |
|||
